PodParley PodParley
PodParley
Program Director's Choice from SABCS2025 - Part 1 : Giredestrant Improves Disease-free Survival in Patients With Early-stage Breast Cancer in Phase III lidERA Trial episode artwork

EPISODE · Jan 21, 2026 · 10 MIN

Program Director's Choice from SABCS2025 - Part 1 : Giredestrant Improves Disease-free Survival in Patients With Early-stage Breast Cancer in Phase III lidERA Trial

from Medical Digest & Congress Report · host Medical Congress News

Kate Lathrop, MD discuss one of the high impact, clinically relevant, clinical trial, the lidERA trial that were presented at the San Antonio Breast Cancer Symposium 2025.Video: https://medicaldigest.org/scientific-contents/interview:program-directors-choice-sabcs2025-part-1-giredestrant-improves-disease-free-survival-patients-early-stage-breast-cancer-phase-iii-lidera-trial

Episode metadata supplied by the publisher feed · Published Jan 21, 2026

Embed this episode

Ready to play

Program Director's Choice from SABCS2025 - Part 1 : Giredestrant Improves Disease-free Survival in Patients With Early-stage Breast Cancer in Phase III lidERA Trial

0:00 10:32

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 10 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on January 21, 2026.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!